Clinical distribution and drug resistance of 825 strains of non-fermentative bacilli
10.3760/cma.j.issn.1008-6706.2013.21.039
- VernacularTitle:非发酵菌825株临床分布特征及耐药性分析
- Author:
Xiao WU
- Publication Type:Journal Article
- Keywords:
Non-fermentative bacilli;
Clinical distribution;
Antibacterial drugs;
Drug resistance
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(21):3287-3289
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the epidemiological status and drug resistance to common antibiotics of non-fermentative bacilli in our hospital,in order to provide the guideline for reasonable use of antibiotics.Methods A total of 825 strains of non-fermentative bacilli from various clinical specimen were analyzed retrospectively.Results A total of 825 strains of non repetitive non-fermentative bacilli were isolated.The first of the three vibrionaceae were 301 strains Pseudomonas Aeruginosa accounted for 36.48％,279 strains of Acinetobacter baumannii accounted for 33.81％,a few malt raise form afterbirth fungus 245 plants accounted for 26.69％.Strains isolated from phlegm,urine and pharynx swab were 580(70.30％),105(12.73％) and 68(8.24％) respectively.Infections with non-fermentative bacilli occurred in the department of respiratory medicine,surgery and ICU were 290 (35.15％),212 (25.70％) and 125 (15.03％) respectively.The susceptibility results of antibiotics showed that the resistant rate of bactrim,Cefotaxime,and Ceftriaxone was beyond 85.00％ with Pseudomonas Aeruginosa.Acinetobacter baumannii strains of Amikacin,Aztreonam,cefotaxime resistance rate was beyond 36.00％,while beyond 95.00％strains of Pseudomonas Aeruginosa and Acinetobacter baumannii were sensitive with Imipenem and Meropenem.The resistant rate of Cefepime,Imipene,m,Meropenem,Cefotaxim-c,Aztreonam was beyond 100.00％ with Stenotrophomonas maltophilia,while which were sensitive with Minocycline.Conclusion Non-fermentative Bacilli hospital infection is the main pathogenic bacteria,and existence multiple drug resistance to antimicrobial agents.
